• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.

作者信息

Nguyen B D, Wang E A

机构信息

Department of Imaging, Johns Hopkins Medical Institutions, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA.

出版信息

Clin Nucl Med. 1999 Feb;24(2):130-1. doi: 10.1097/00003072-199902000-00016.

DOI:10.1097/00003072-199902000-00016
PMID:9988077
Abstract
摘要

相似文献

1
Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.
Clin Nucl Med. 1999 Feb;24(2):130-1. doi: 10.1097/00003072-199902000-00016.
2
[Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].[利用铟-111奥曲肽闪烁扫描术检测肿瘤性骨软化症的原发肿瘤部位：一例报告]
Rinsho Shinkeigaku. 2008 Feb;48(2):120-4. doi: 10.5692/clinicalneurol.48.120.
3
Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia.奥曲肽扫描在检测引起低磷性骨软化症的耻骨联合间叶组织肿瘤中的应用
Int Orthop. 2002;26(1):61-2. doi: 10.1007/s00264-001-0318-0.
4
Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.铟-111奥曲肽闪烁扫描术检测到的与间充质肿瘤相关的致癌性骨软化症
Clin Endocrinol (Oxf). 2001 Apr;54(4):551-4. doi: 10.1046/j.1365-2265.2001.01056.x.
5
Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.生长抑素受体闪烁扫描术在肿瘤诱导性骨软化症治疗中的临床影响
Clin Nucl Med. 2008 Nov;33(11):752-6. doi: 10.1097/RLU.0b013e31818866bf.
6
Occult phosphaturic mesenchymal tumor detected by Tc-99m sestamibi scan.通过锝-99m 司他米比扫描检测到的隐匿性促磷酸尿性间叶肿瘤。
Clin Nucl Med. 2002 Aug;27(8):608-9. doi: 10.1097/00003072-200208000-00019.
7
Imaging of oncogenic osteomalacia.
Isr Med Assoc J. 2007 Jul;9(7):566-7.
8
Tumor-induced osteomalacia: a case report.肿瘤诱导的骨软化症：一例报告。
Arq Bras Endocrinol Metabol. 2009 Apr;53(3):378-82. doi: 10.1590/s0004-27302009000300014.
9
[Tumor-induced osteomalacia in a patient with a phosphaturic mesenchymal tumor revealing feature of an ossifying fasciitis of the left abdominal wall].[一名患有磷尿性间充质瘤的患者出现肿瘤性骨软化症，其左腹壁表现为骨化性筋膜炎的特征]
Nihon Naika Gakkai Zasshi. 2002 Jun 10;91(6):1870-2. doi: 10.2169/naika.91.1870.
10
Localisation of mesenchymal tumours by somatostatin receptor imaging.生长抑素受体显像对间充质肿瘤的定位
Lancet. 2002 Mar 2;359(9308):761-3. doi: 10.1016/s0140-6736(02)07846-7.

引用本文的文献

1
Case Report with Literature Review: Tumor-induced osteomalacia from a soft-tissue phosphaturic mesenchymal tumor of the trunk.病例报告及文献综述：躯干软组织磷酸酶分泌性间叶肿瘤所致肿瘤性骨软化症
Front Endocrinol (Lausanne). 2025 Sep 18;16:1655376. doi: 10.3389/fendo.2025.1655376. eCollection 2025.
2
Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.脊柱磷酸盐尿性间叶性肿瘤：导致肿瘤性骨软化症的罕见病因——英国三级转诊中心的经验回顾和文献复习。
Eur Spine J. 2024 May;33(5):1911-1920. doi: 10.1007/s00586-023-08031-6. Epub 2023 Nov 14.
3
Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.
包括系统性成纤维细胞生长因子23静脉采样在内的多模态方法在定位磷尿性间叶肿瘤中的应用
J Endocr Soc. 2022 Nov 24;7(2):bvac181. doi: 10.1210/jendso/bvac181. eCollection 2022 Dec 15.
4
Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.儿童磷代谢紊乱，第 2 部分：低磷血症和高磷血症性疾病。
Pediatr Radiol. 2022 Nov;52(12):2290-2305. doi: 10.1007/s00247-022-05373-z. Epub 2022 May 10.
5
Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.饮酒导致与成纤维细胞生长因子23相关的低磷性骨软化症
Bone Rep. 2021 Oct 16;15:101144. doi: 10.1016/j.bonr.2021.101144. eCollection 2021 Dec.
6
Occult tumour-induced osteomalacia causing lesion detected by FDG-PET/CT scan.
World J Nucl Med. 2020 Jan 17;19(2):147-148. doi: 10.4103/wjnm.WJNM_68_19. eCollection 2020 Apr-Jun.
7
Intramastoid Phosphaturic Mesenchymal Tumor Causing Hypophosphatemic Osteomalacia Detected on Ga-DOTATATE PET/CT But Not on Tc-Sestamibi and F-FDG Scans.在镓- DOTATATE PET/CT上检测到但在锝-司他比和氟代脱氧葡萄糖扫描上未检测到的引起低磷性骨软化症的乳突内磷酸化间充质肿瘤。
Nucl Med Mol Imaging. 2019 Dec;53(6):436-441. doi: 10.1007/s13139-019-00616-8. Epub 2019 Nov 14.
8
Tumor-induced osteomalacia.肿瘤诱导的骨软化症
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
9
Imaging features of phosphaturic mesenchymal tumors.磷酸尿性间叶肿瘤的影像学特征。
Skeletal Radiol. 2019 Jan;48(1):119-127. doi: 10.1007/s00256-018-3014-5. Epub 2018 Jul 9.
10
Diagnostic performance and impact on patient management of Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.镓- DOTATOC PET/CT 检测骨软化症相关肿瘤的诊断性能及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12.